Why won't the sliding scale go away?

Canadian Journal of Diabetes

Volumn 35, Issue 4, 2011, Pages 340-343

  Miller, David B ^a  

^a VANCOUVER ISLAND HEALTH AUTHORITY   (Canada)

Author keywords

Hospital management; Insulin ordering; Sliding scale

Indexed keywords

BASAL BOLUS SUPPLEMENT INSULIN; GLUCOSE; INSULIN; SLIDING SCALE INSULIN; UNCLASSIFIED DRUG;

ARTICLE; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DRUG EFFICACY; EVIDENCE BASED MEDICINE; EVIDENCE BASED PRACTICE; EXPERIENCE; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; MORBIDITY;

EID: 80054121354     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-2671(11)54010-9     Document Type: Article

References (17)

1. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.
2. Malmberg K. Prospective randomized study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ. 1997;314:1512-1515.
3. Queale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Int Med. 1997;157:545-552.
4. Inzucchi SE. Management of hyperglycemia in the hospital setting. N Engl J Med. 2006;355:1903-1911.
5. Umpierrez GE, Palacio A, Smiley D. Sliding scale insulin use: myth or insanity? Am J Med. 2007;120:563-567.
6. Hirsch IB. Sliding scale insulin - time to stop sliding. JAMA. 2009; 301:213-214.
7. Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27:553-591.
8. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2005;28:S4-S36.
9. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2008;32(suppl 1):S1-S201.
10. Mooradian AD, Bernbaum M, Albert SG. Narrative review: a rational approach to starting insulin therapy. Ann Intern Med. 2006;145:125-134.
11. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
12. Becker T, Moldoveanu A, Cukierman T, Gerstein HC. Clinical outcomes associated with the use of subcutaneous insulin-by-glucose sliding scales to manage hyperglycemia in hospitalized patients with pneumonia. Diabetes Res Clin Pract. 2007;78:392-397.
13. Umpierrez GE, Smiley D, Zisman A, et al. Randomized study of basalbolus insulin therapy in the inpatient management of type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007;30:2181-2186.
14. Kitibachi AE, Nwenye E. Sliding-scale insulin: more evidence needed before final exit? Diabetes Care. 2007;30:2409-2410.
15. Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basalbolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011;34:256-261.
16. Yale JF, Begg I, Gerstein H, et al. 2001 Canadian Diabetes Association clinical practice guidelines for the prevention and management of hypoglycemia in diabetes. Can J Diabetes. 2001;26:22-35.
17. Clemens E, Cutler T, Canaria J, Prescriber compliance with a new computerized insulin guideline for noncritically ill adults. Ann Pharmacother. 2011;45:154-161.